Lawmakers query FDA on labeling rule
Eight House and Senate health overseers are challenging the FDA's use of limited resources to prepare a proposed rule on when medical product companies can make safety-related labeling changes without prior approval.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.